HomeOwner Search
Visit USCO2017
Category SearchPulmonary Pharmacology & Therapeutics [Published: 2017-08-07. Issue: no. 45, August 2017]
Serial Registration
Copyright Title
Pulmonary Pharmacology & Therapeutics [Published: 2017-08-07. Issue: no. 45, August 2017]
Status
Published
on 22 Aug 2017
Year of Creation
2017
Copyright Claimant
Elsevier
Registration Number
TX0008485085
on 22 Aug 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008485085) dated 22 Aug 2017, pertains to an electronic file (eService) titled "Pulmonary Pharmacology & Therapeutics [Published: 2017-08-07. Issue: no. 45, August 2017]" created in 2017. The copyright holder is Elsevier, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier.
Application Details
Registration Number
TX0008485085
Registration Date
8/22/2017
Year of Creation
2017
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Elsevier
First Publication Nation
United Kingdom
ISSN
1094-5539
Preexisting Material
Permissioned materials
Notes
Rights Note: permissions@elsevier.com
Copyright Local Holdings: no. 45, August 2017 Created 2017 Pub. 2017-08-07 Reg. 2017-09-20 TX0008485085 MLEI
Material Matter Claimed Note: compilation, editing, text, figures
Statements
Application Title Statement: Pulmonary Pharmacology & Therapeutics
Author Statement: Elsevier employer for hire Domicile: United Kingdom Citizenship: United Kingdom Authorship: compilation
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.